Takeover

SIGASIGA TECHNOLOGIES INC

Pharmaceutical Preparations

Revenue
$95MFY2021: $134MFY2022: $111MFY2023: $140MFY2024: $139MFY2025: $95M
32% YoY
Operating margin
25.1%FY2021: 66.7%FY2022: 38.5%FY2023: 59.8%FY2024: 50.4%FY2025: 25.1%
50% YoY
EBITDA
$24MFY2021: $90MFY2022: $43MFY2023: $84MFY2024: $71MFY2025: $24M
66% YoY
Market cap
$218M
Employees
—
Net debt / EBITDA
-4.8×
−$116M net debt
AI in 10-K
0.4
mentions per 10K words

Takeover score 2 of 13

Fixable underperformance 0 of 7

Buyer economics 2 of 4

Catalysts 0 of 2

Financials

MetricFY2021FY2022FY2023FY2024FY2025YoYTrend
Revenue$134M$111M$140M$139M$95M 32% FY2021: $134MFY2022: $111MFY2023: $140MFY2024: $139MFY2025: $95M
Operating income$89M$43M$84M$70M$24M 66% FY2021: $89MFY2022: $43MFY2023: $84MFY2024: $70MFY2025: $24M
Net income$69M$34M$68M$59M$23M 61% FY2021: $69MFY2022: $34MFY2023: $68MFY2024: $59MFY2025: $23M
Operating cash flow$11M$42M$95M$49M$43M 11% FY2021: $11MFY2022: $42MFY2023: $95MFY2024: $49MFY2025: $43M
Stock-based comp$1M$2M$2M$4M$4M 1.2% FY2021: $1MFY2022: $2MFY2023: $2MFY2024: $4MFY2025: $4M
Buybacks$26M$13M$11M$0$0FY2021: $26MFY2022: $13MFY2023: $11MFY2024: $0FY2025: $0
Dividends$0$33M$32M$43M$43M 1.1% FY2021: $0FY2022: $33MFY2023: $32MFY2024: $43MFY2025: $43M

Deal filings

FiledFormAcquirerPricePremium
Jun 30, 2006PREM14APharmAthene, Inc.$1.38—

13D filers

FiledFilerFormStakeIntent
Nov 22, 2021ESOPUS CREEK VALUE SERIES FUND LP - SERIES ASC 13D/A4.2%Passive
Sep 17, 2021MacAndrews & Forbes Inc.SC 13D/A32.2%Passive
Aug 17, 2021ESOPUS CREEK VALUE SERIES FUND LP - SERIES ASC 13D/A3.2%Active
Feb 23, 2021ESOPUS CREEK VALUE SERIES FUND LP - SERIES ASC 13D7.0%Active
May 14, 2020ESOPUS CREEK VALUE SERIES FUND LP - SERIES ASC 13D/A4.3%Passive
Feb 25, 2020ESOPUS CREEK VALUE SERIES FUND LP - SERIES ASC 13D/A4.3%Passive
Feb 13, 2020ESOPUS CREEK VALUE SERIES FUND LP - SERIES ASC 13D/A8.6%Passive
Feb 13, 2020ESOPUS CREEK VALUE SERIES FUND LP - SERIES ASC 13D8.6%Passive

Insider trading

No open-market trades in the last 12 months.

Pay vs performance

YearCEO total compComp actually paidTSR (indexed)Peer TSR
FY2025$3M$4M116120
FY2024$5M$6M10491
FY2023$2M$2M8892
FY2022$2M$2M10789
FY2021$2M$2M10399